Table 5. Cardiovascular Outcome and Recurrent Angina Up to 5 Years.
Variables, % | Entire patients | Matched patients | ||||
---|---|---|---|---|---|---|
Diltiazem (n=842) | Dual (n=1899) | p value | Diltiazem (n=811) | Dual (n=811) | p value | |
Total death | 0.0 | 0.9 | 0.050 | 0.0 | 1.1 | 0.039 |
Cardiac death | 0.0 | 0.3 | 0.156 | 0.0 | 0.1 | 1.000 |
Myocardial infarction | 1.0 | 0.6 | 0.564 | 1.0 | 0.2 | 0.492 |
Revascularization | 0.6 | 1.4 | 0.264 | 0.6 | 1.1 | 0.811 |
Total major adverse cardiac events | 0.8 | 2.3 | 0.052 | 0.6 | 2.2 | 0.248 |
Recurrent angina | 8.3 | 0011.7 | 0.001 | 8.3 | 8.2 | 0.276 |